Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fuchs

Showing results (1-10 of 373) with videos related to

Pageof 38
Sort By:
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Managing the Silent Epidemic of Nonalcoholic Fatty Liver DiseaseMichael Fuchs
The Journal of Gene Medicine|October 28, 2006
Gene therapy. An ethical profile of a new medical territoryMichael Fuchs
Human Reproduction and Genetic Ethics|April 27, 2012
Reshaping human intelligence: the debate about genetic enhancement of cognitive functionsMichael Fuchs
Journal of Lipids|December 22, 2011
Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment targetMichael Fuchs
Deutsche Medizinische Wochenschrift (1946)|April 4, 2018
[Hodgkin Lymphoma - Update 2018]Michael Fuchs
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Ethical considerationMichael Fuchs
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin|March 12, 2003
[Physical fitness in space: measures to prevent muscular atrophy]Michael Fuchs
Current Treatment Options in Gastroenterology|March 22, 2015
New medical treatment strategies for nonalcoholic steatohepatitisMichael Fuchs
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 20, 2025
Shape parameters of evolutionary trees in theoretical computer scienceMichael Fuchs
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 13, 2003
Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challengesMichael Fuchs
Pageof 38

Showing results (1-10 of 373) with videos related to

Sort By:
Pageof 38
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Managing the Silent Epidemic of Nonalcoholic Fatty Liver DiseaseMichael Fuchs
The Journal of Gene Medicine|October 28, 2006
Gene therapy. An ethical profile of a new medical territoryMichael Fuchs
Human Reproduction and Genetic Ethics|April 27, 2012
Reshaping human intelligence: the debate about genetic enhancement of cognitive functionsMichael Fuchs
Journal of Lipids|December 22, 2011
Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment targetMichael Fuchs
Deutsche Medizinische Wochenschrift (1946)|April 4, 2018
[Hodgkin Lymphoma - Update 2018]Michael Fuchs
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Ethical considerationMichael Fuchs
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin|March 12, 2003
[Physical fitness in space: measures to prevent muscular atrophy]Michael Fuchs
Current Treatment Options in Gastroenterology|March 22, 2015
New medical treatment strategies for nonalcoholic steatohepatitisMichael Fuchs
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 20, 2025
Shape parameters of evolutionary trees in theoretical computer scienceMichael Fuchs
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 13, 2003
Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challengesMichael Fuchs
Pageof 38